Clinical TrialsSearch results
Number of results: 535
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase II study of percutaneous osteoplasty for painful malignant bone tumor (JIVROSG-0703)
- Malignant vertebral and pelvic bone tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of percutaneous radiofrequency ablation for malignant lung tumor (JIVROSG-0702)
- Malignant lung tumor
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2008-11-12
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20
Other
- a phase II trial of amrubicin and carboplatin for patients with extensive stage small cell lung cancer
- small cell lung cancer
- Nagasaki Thoracic Oncology Group
- 2008-04-09
Other
- A phase II, multicenter, study for newly diagnosed glioblastomas using boron neutron capture therapy, additional X-ray treatment and chemotherapy
- Newly-diagnosed glioblastoma
- Dept. of Neurosurgery, Osaka Medical College
- 2009-09-01
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26
Other
- A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
- small (2 cm or less) peripheral non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-08-10
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22
Other
- A Phase III Study Comparing Etoposide and Cisplatin (EP) with Irinotecan and Cisplatin (IP) following EP plus Concurrent Accelerated Hyperfractionated Thoracic Irradiation (EP/TRT) for the Treatment of Limited-Stage Small-Cell Lung Cancer (EP/TRT-IPIII): JCOG0202-MF
- Limited-Stage Small-Cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-08-30